Health Medical Pharma

Abbott gets FDA nod for software to help doctors open blocked arteries

May 3, 2026: The US Food and Drug Administration has cleared Abbott Laboratories’ new artificial-intelligence-powered software for coronary imaging, enabling doctors to have.

Read More